Similarly, a metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in patients with high-risk non-small-cell lung cancer showed a decrease in vegf levels during treatment 38. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.